Dataset Information


Hearing Assessment after Treatment of Nasopharyngeal Carcinoma with CRT and IMRT Techniques.



This study analyzed the long-term hearing loss after treatment of primary nasopharyngeal carcinoma to elucidate its causal factors.


Ninety-two nasopharyngeal carcinoma patients were treated with radiotherapy or chemoradiotherapy. Pure tone audiometry was performed before the therapy and annually up to 9 years after completing treatment. The hearing thresholds were corrected for age-related deterioration and compared to the results without adjusting for age.


The mean air and bone conduction threshold with and without correction for age-related deterioration differed significantly 2-9 years after completing radiotherapy (p < 0.05). The audiometry results with age correction showed a flattened configuration compared to the results without age correction. The total radiation dose and radiation modality showed a causal relationship with a greater incidence of hearing loss after therapy (p < 0.05). There was more deterioration in the air and bone hearing thresholds with conformal radiotherapy than intensity-modulated radiotherapy (p < 0.001). A radiation dose >72?cGy resulted in more severe hearing loss than <72?cGy (p < 0.05).


Hearing loss after completing therapy should be corrected for age-related hearing deterioration to reveal the true extent to which the loss is a therapeutic complication. Both the radiation modality used and the dose were significantly associated with hearing loss.


PROVIDER: S-EPMC4553178 | BioStudies | 2015-01-01

REPOSITORIES: biostudies

Similar Datasets

2018-01-01 | S-EPMC6335470 | BioStudies
2020-01-01 | S-EPMC7655471 | BioStudies
2020-01-01 | S-EPMC7688380 | BioStudies
2018-01-01 | S-EPMC6202674 | BioStudies
2015-01-01 | S-EPMC4657906 | BioStudies
2020-01-01 | S-EPMC6984733 | BioStudies
2017-01-01 | S-EPMC5309283 | BioStudies
2019-01-01 | S-EPMC6946454 | BioStudies
2018-01-01 | S-EPMC6245203 | BioStudies
1000-01-01 | S-EPMC6251249 | BioStudies